Fed Trapped at 3.50-3.75% as Iran Conflict Ignites Oil-Fueled Inflation Shock
The Fed's 3.50-3.75% rate hold faces stress tests as Middle East conflict drives energy volatility and sticky inflation above the 2% target.
Vertex's Kidney Trial Win: Progress or Peril for Biotech Bulls?
Vertex Pharmaceuticals surged 4% on rare disease trial success, but investors should weigh pipeline risks against diversification hopes.
TSX Materials Rally Outpaces US Markets as Gold Hits Record Highs
Oracle's Cloud Ascendancy: Can It Weather the AI Storm?
Oracle's Q3 earnings beat underscores its successful cloud pivot, but can it maintain momentum amid intensifying AI infrastructure demands?
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.